# Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study)

> **NCT05268419** · PHASE3 · COMPLETED · sponsor: **Ali Amoushahi** · enrollment: 150 (actual)

## Conditions studied

- Clinical Infection
- Outcome
- Morality

## Interventions

- **DRUG:** Ethanol
- **DRUG:** Water Distilled

## Key facts

- **NCT ID:** NCT05268419
- **Lead sponsor:** Ali Amoushahi
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-02
- **Primary completion:** 2021-11-16
- **Final completion:** 2021-12-16
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2022-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05268419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05268419, "Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study)". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT05268419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*